Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AQIA is a leading Brazilian company specializing in the development, manufacture, and distribution of high-performance chemical ingredients for the personal care, pharmaceutical, and food industries. Founded in 1984 and headquartered in Guarulhos, the company provides a wide range of active ingredients, functional excipients, and botanical extracts used in advanced dermatological and cosmetic formulations. In 2022, AQIA was acquired by Barentz, a global leader in life science ingredients, which significantly expanded its reach and technical capabilities within the Latin American market. The company is recognized for its commitment to innovation and sustainability, offering proprietary technologies that address global trends such as clean beauty and green chemistry. AQIA serves as a strategic partner for both local and multinational brands, providing comprehensive technical support and customized formulation services. Its portfolio includes specialized solutions for skin care, hair care, and pharmaceutical drug delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AQIA.